These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 1181321)

  • 1. Antagonism of the effects of d-amphetamine by amantadine and other stimulants, analeptics and anorexics in mice.
    Clark WG; Yuen L
    Int J Neurol; 1975; 10(1-4):68-79. PubMed ID: 1181321
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of the central effects of d-amphetamine by amantadine. II.
    Prepas S; Menon MK; Clark WG
    Arzneimittelforschung; 1975 May; 25(5):780-2. PubMed ID: 1242323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locomotor effects of amperozide. Antagonism of amphetamine-induced locomotor stimulation.
    Egbe PC
    Arzneimittelforschung; 1989 Oct; 39(10):1223-4. PubMed ID: 2514690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice.
    Clark R; Smith DH; Vernier VG; Rubin AA
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):434-6. PubMed ID: 1061960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of d- and 1-amphetamine on spontaneous motor activity in mice.
    Maickel RP; Levine RM; Quirce CM
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):711-4. PubMed ID: 4420179
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.
    Menon MK; Vivonia CA; Haddox VG
    Psychopharmacology (Berl); 1984; 82(1-2):89-92. PubMed ID: 6141587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice.
    Tyhon A; Lakaye B; Grisar T; Tirelli E
    Pharmacol Biochem Behav; 2008 Feb; 88(4):446-55. PubMed ID: 17996928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Locomotor activity and expression of c-Fos protein in the brain of C57BL and Balb/c mice: effects of D-amphetamine and sydnocarb].
    Novoselov IA; Cherepov AB; Raevskiĭ KS; Anokhin KV
    Eksp Klin Farmakol; 2002; 65(5):18-21. PubMed ID: 12596507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enhancement and inhibition of stimulating amphetamine effects by drugs with central-depressant properties].
    Müller H; Schoetensack W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):285-7. PubMed ID: 4242429
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of antagonists of the various subtypes of dopamine receptors on the locomotor activity of C57BL mice induced by psychostimulators].
    Novoselov IA; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(6):3-5. PubMed ID: 14743700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
    Biala G; Kruk M
    J Pharm Pharmacol; 2009 Apr; 61(4):493-502. PubMed ID: 19298697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavioral changes produced by chronic administration of d-amphetamine in mice].
    Carranza-Acevedo J; Ortega-Corona BG; Ordóñez S; Castro-Osuna G
    Arch Invest Med (Mex); 1970; 1(3):221-6. PubMed ID: 5524578
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential amphetamine antagonist, adamantanamine derivative of fluphenazine.
    Ho BT; Englert LF; McKenna ML
    J Med Chem; 1976 Jun; 19(6):850-2. PubMed ID: 950658
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in the structure of the agonistic behavior of mice produced by D-amphetamine.
    Moro M; Salvador A; Simón VM
    Pharmacol Biochem Behav; 1997 Jan; 56(1):47-54. PubMed ID: 8981608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
    Miller DK; Dopheide MM; Smith SM; Casteel SW
    Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between locomotor activity changes produced by phencyclidine and D-amphetamine in CD-1 male mice.
    Stavchansky S; Riffee W; Geary R
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):189-202. PubMed ID: 4023408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.